Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Caillard

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Nephrologie & Therapeutique|February 5, 2010
[Benefits of proliferation signal inhibitors beyond immunosuppression. Vascular protection and experience in heart transplantation]S Caillard
La Revue Du Praticien|September 29, 2000
[Disorders of acid-balance balance. Physiopathology, diagnosis, treatment]T Hannedouche, S Caillard
Annales D'Endocrinologie|March 10, 2001
[Kidney and statins]B Moulin, S Caillard
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working GroupS Caillard, V Lachat, B Moulin
Nephrologie & Therapeutique|November 13, 2008
[Transplantation of patients with cardiovascular risk]S Caillard, O Inhoff, B Moulin
Nephrologie & Therapeutique|September 26, 2008
[Methods of assessment of the renal function in kidney transplant patients]M Brucker, S Caillard, B Moulin
Nephrologie|July 24, 1998
[The "absolute" cardiovascular risk]T Hannedouche, M Bouiller, S Caillard
Nephrologie|July 24, 1998
[Absolute cardiovascular risk among nephrology patients]T Hannedouche, M Bouiller, S Caillard
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 20, 2006
Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French RegistryS Caillard, C Lelong, F Pessione, et al.
Nephrologie|December 11, 1999
[Tubular hypokalemia of genetic origin]I Kolb, Y Dimitrov, S Caillard, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Nephrologie & Therapeutique|February 5, 2010
[Benefits of proliferation signal inhibitors beyond immunosuppression. Vascular protection and experience in heart transplantation]S Caillard
La Revue Du Praticien|September 29, 2000
[Disorders of acid-balance balance. Physiopathology, diagnosis, treatment]T Hannedouche, S Caillard
Annales D'Endocrinologie|March 10, 2001
[Kidney and statins]B Moulin, S Caillard
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working GroupS Caillard, V Lachat, B Moulin
Nephrologie & Therapeutique|November 13, 2008
[Transplantation of patients with cardiovascular risk]S Caillard, O Inhoff, B Moulin
Nephrologie & Therapeutique|September 26, 2008
[Methods of assessment of the renal function in kidney transplant patients]M Brucker, S Caillard, B Moulin
Nephrologie|July 24, 1998
[The "absolute" cardiovascular risk]T Hannedouche, M Bouiller, S Caillard
Nephrologie|July 24, 1998
[Absolute cardiovascular risk among nephrology patients]T Hannedouche, M Bouiller, S Caillard
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 20, 2006
Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French RegistryS Caillard, C Lelong, F Pessione, et al.
Nephrologie|December 11, 1999
[Tubular hypokalemia of genetic origin]I Kolb, Y Dimitrov, S Caillard, et al.
Pageof 4